Schedule 13D ownership disclosure
CM Life Sciences Inc
Security class unavailable · CUSIP: 18978W109
Event date: 2022-04-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 17,730,419
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-023581
- Form type
- SC 13D
- Filer
- CMLS Holdings LLC
- CIK
- CIK 1822257
- Filed
- May 03, 2022
- Reporting period
- Apr 29, 2022
- Description
- Schedule 13D beneficial ownership